ClinicalTrials.gg
Drug

Levoleucovorin clinical trials

Includes 6 studies of Levoleucovorin calcium.

studies test it
12
open now
0
in phase 3
5
first study started
1997

How each study uses Levoleucovorin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
7 Mar 2008 · FUSILEV · NDA 020140 (FDA, Drugs@FDA; as levoleucovorin calcium)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

L-leucovorin
3
Levoleucovorin
2
Fusilev
2

Studies by the year they started

12 studies that test it; most in 2013 (3)

Studies that test Levoleucovorin, by start year
YearStudies
19971
20022
20051
20133
20141
20151
20202
20231

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
5
Phase 3
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 6 · Other 6

Southwest Autism Research & Resource Center (2) · Takeda (2) · Wyeth is now a wholly owned subsidiary of Pfizer (2) · Acrotech Biopharma Inc. (2) · Institute of Cancer Research, United Kingdom (1) · Gruppo Oncologico del Nord-Ovest (1) · Hokkaido Gastrointestinal Cancer Study Group (1) · Universiteit Antwerpen (1)

Often tested with

Tested in the same studies.

Fluorouracil (5) · Oxaliplatin (4) · Panitumumab (2) · Pralatrexate (2) · Bevacizumab (1) · Irinotecan (1) · Trifluridine tipiracil drug combination (1) · Tucatinib (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 3 phase 3 studies under way

Levoleucovorin is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 1

Studies that test Levoleucovorin.

Studies

Open first, then newest update. How each study uses Levoleucovorin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 12

Given beside what is tested · 48 — Levoleucovorin is usual care or a partner of the new treatment

Showing 20 of 48.

As the comparator · 8 — what is tested is compared with Levoleucovorin

Codes

What other systems call Levoleucovorin · ClinicalTrials.gg INT008929

  • MeSH (NLM) D058766LevoleucovorinConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 990S25980YLEVOLEUCOVORINConfirmed FDA, NLM
  • RxNorm 877015One source FDA
  • NCI Thesaurus C1559LevoleucovorinOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.